CompletedPhase 3

Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment

Indonesia36 participantsStarted 2023-08-26

Plain-language summary

The goal of this clinical trial is to compare 0,1% topical low molecular weight (7 kDa) hyaluronic acid with 0,1% high molecular weight (1.800 kDa) hyaluronic acid as therapy of xerotic skin in elderly

Who can participate

Age range60 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female or male diagnosed with xerotic skin * 60-80 years old * Willing to participate in clinical trial and sign informed consent Exclusion Criteria: * History of hypersensitivity to moisturizer * Dermatitis or any dermatosis on intervention area in the leg * Score of erythema and crack more than 2, based on SRRC scoring

What they're measuring

Skin capacitance

Timeframe: 2 weeks and 4 weeks

Transepidermal water loss

Timeframe: 2 weeks and 4 weeks

Specified symptom sum score/scale, roughness, redness, crack (SRRC)

Timeframe: 2 weeks and 4 weeks

Trial details

NCT IDNCT06178367

SponsorIndonesia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Xerosis Cutis trials